Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

(D8220C00027-MAJIC): A Phase III Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib plus Venetoclax versus Venetoclax plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  • Details

ClinicalTrials.gov ID: NCT05057494
Diagnosis Type: Lymphomas
USOR Number: 21228

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase IB/II, 2-Stage, Open-label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab (MEDI4736) + Paclitaxel andDurvalumab (MEDI4736) in Combination With Novel Oncology TherapiesWith or Without Paclitaxel for First-line Metastatic Triple Negative Breast Cancer (D933LC00001)

  • Details

ClinicalTrials.gov ID: NCT03742102
Diagnosis Type: Breast Cancer
USOR Number: 20417

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib following Definitive Locoregional Treatment in Participants with Stage IB-IIIA RET fusion-Positive NSCLC (LIBRETTO-432) (J2G-MC-JZJX)

  • Details

ClinicalTrials.gov ID: NCT04819100
Diagnosis Type: Lung Cancer
USOR Number: 20412

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3, Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN-MCL-321)(LOXO-BTK-20019)

  • Details

ClinicalTrials.gov ID: NCT04662255
Diagnosis Type: Lymphomas
USOR Number: 20336

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Myelomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase II trial of daratumumab, lenalidomide and dexamethasone (DRd) in combination with selinexor for patients with newly diagnosed multiple myeloma (USOR 20285)

  • Details

ClinicalTrials.gov ID: NCT04782687
Diagnosis Type: Myelomas
USOR Number: 20285

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Solid Tumors

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies (SGN35-033)

  • Details

ClinicalTrials.gov ID: NCT04609566
Diagnosis Type: Solid Tumors
USOR Number: 20283

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (INCMGA 0012-204/ POD1UM-204)

  • Details

ClinicalTrials.gov ID: NCT04463771
Diagnosis Type: Endometrial Cancer
USOR Number: 20176

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects < or = 70 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma (ACE-LY-312/ D8227C00001)

  • Details

ClinicalTrials.gov ID: NCT04529772
Diagnosis Type: Lymphomas
USOR Number: 20175

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Solid Tumors

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: Solid Tumors
USOR Number: 19151

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Solid Tumors

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: Solid Tumors
USOR Number: 19151

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 683-5001

More Details View Practice Page